Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.

Site Map

Site Map of http://www.researchandmarkets.com


Site Map
Pharmaceuticals and Healthcare
   Pharmaceuticals 1 (Latest Titles)
   Pharmaceuticals 2
   Pharmaceuticals 3
   Pharmaceuticals 4

      Infectious Diseases  << You are in This Category




#  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  


A

Advances in the Treatment of Serious Systemic Fungal Infections--An Update static version printer friendly pdf version
Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery static version printer friendly pdf version
Antibacterial Drug Licensing Opportunities: Analysis, Rating, and Ranking - A Worldwide Study static version printer friendly pdf version
Antibacterial Market Survey: Analyses and Forecasts…Technology, Sales and Company Profiles static version printer friendly pdf version
Antibacterial: Drug Licensing Opportunities, 2002  static version printer friendly pdf version
Antibiotic Resistance: Opinion Leader Forum, 2002 static version printer friendly pdf version
Antiviral Drug Licensing Opportunities: Analysis, Rating, and Ranking - A Worldwide Study static version printer friendly pdf version
Antiviral Resistance: Innovation Reshaping Viral Treatment, 2001 Edition static version printer friendly pdf version
Antivirals - A Broad Market Overview static version printer friendly pdf version
Approved AIDS and AIDS-Related Drugs, 1987-2003 static version printer friendly pdf version
Autoimmune/Inflammatory Disease Drug Licensing Opportunities: Analysis, Rating and Ranking - A Worldwide Study static version printer friendly pdf version
Autoimmune/Inflammatory Disease: Competitive Strategies - Competitive Analysis, Profiles, and Portfolio Strategies of the Top Autoimmune/Inflammatory Therapeutic Manufacturers in the US (2001 Edition) static version printer friendly pdf version
Avian Influenza: The Threatening Pandemic static version printer friendly pdf version


^ Top



B

Bacterial Infections: An Epidemiological Overview static version printer friendly pdf version
Bacterial Infections: An Epidemiological Overview static version printer friendly pdf version


^ Top



C

Chinese Markets for HIV Treatment Drugs static version printer friendly pdf version
Commercial Insight: HIV - Change of Guard static version printer friendly pdf version
Commercial Insight: HIV in the USA - Increasing Choice, Flexibility and Competition static version printer friendly pdf version


^ Top



D

Disease & Therapy Review (DTR) Executive Market Summaries static version printer friendly pdf version
Disease and Therapy Review: Hepatitis B static version printer friendly pdf version
Disease and Therapy Review: Hepatitis C static version printer friendly pdf version
Drugs and Vaccines in Development of Infectious Diseases, 2004 static version printer friendly pdf version
Drugs of Tomorrow 2001: Bacterial Infections static version printer friendly pdf version
Drugs of Tomorrow 2001: Hepatitis - The Succession of New Generation Therapies static version printer friendly pdf version


^ Top



F

Fierce Competition for a Shrinking HCV Market static version printer friendly pdf version


^ Top



H

Hepatitis C virus (HCV) - Fierce Competition for a Shrinking HCV Market?  static version printer friendly pdf version
Hepatitis C virus (HCV) - Future HCV Drug Discovery Technologies static version printer friendly pdf version
HIV Pricing Strategies in the US and UK static version printer friendly pdf version
HIV Update 2002 (11) - November static version printer friendly pdf version
HIV Update 2002 (12) - December static version printer friendly pdf version
HIV Update 2003 (1) - January static version printer friendly pdf version
HIV Update 2003 (2) - February static version printer friendly pdf version
HIV Update 2003 (3) - March static version printer friendly pdf version
Human Virology static version printer friendly pdf version


^ Top



I

ICAAC 2007 Leadership Summit: Discussion among Nine Infectious Disease Specialists static version printer friendly pdf version
Infections - AIDS HIV Drug Pipeline Report static version printer friendly pdf version
Infections - Bacterial Infections Drug Pipeline Report static version printer friendly pdf version
Infections - Ear Infections Drug Pipeline Report static version printer friendly pdf version
Infections - Fever Drug Pipeline Report static version printer friendly pdf version
Infections - Fungal Infections or Candidiasis Drug Pipeline Report static version printer friendly pdf version
Infections - Helminthic Infestations Drug Pipeline Report static version printer friendly pdf version
Infections - Hepatitis B Drug Pipeline Report static version printer friendly pdf version
Infections - Hepatitis C Drug Pipeline Report static version printer friendly pdf version
Infections - Herpes Simplex Virus Infection Drug Pipeline Report static version printer friendly pdf version
Infections - Influenza Drug Pipeline Report static version printer friendly pdf version
Infections - Malaria Drug Pipeline Report static version printer friendly pdf version
Infections - Pneumonia Drug Pipeline Report static version printer friendly pdf version
Infections - Staphylococcal Infections Drug Pipeline Report static version printer friendly pdf version
Infections - Tuberculosis Drug Pipeline Report static version printer friendly pdf version
Infections - Urinary Tract Infections Drug Pipeline Report static version printer friendly pdf version
Infections - Viral Infections static version printer friendly pdf version
Infections - Viral Infections Drug Pipeline Report static version printer friendly pdf version
Infections AIDS HIV  static version printer friendly pdf version
Infections Bacterial Infections  static version printer friendly pdf version
Infections Ear Infections  static version printer friendly pdf version
Infections Fever  static version printer friendly pdf version
Infections Fungal Infections or Candidiasis  static version printer friendly pdf version
Infections Helminthic Infestations  static version printer friendly pdf version
Infections Hepatitis B  static version printer friendly pdf version
Infections Hepatitis C  static version printer friendly pdf version
Infections Herpes Simplex Virus Infection  static version printer friendly pdf version
Infections Influenza  static version printer friendly pdf version
Infections Malaria  static version printer friendly pdf version
Infections Pneumonia  static version printer friendly pdf version
Infections Staphylococcal Infections  static version printer friendly pdf version
Infections Tuberculosis  static version printer friendly pdf version
Infections Urinary Tract Infections  static version printer friendly pdf version
Interferon Current Market Dynamics & Future Outlook static version printer friendly pdf version


^ Top



M

Market Dynamics 2001: Bacterial Infections static version printer friendly pdf version
Market Dynamics 2001: Hepatitis B&C - The Succession of New Generation Therapies static version printer friendly pdf version
Molecular Approaches Towards Hepatitis C virus (HCV) Therapy - The Complete Guide static version printer friendly pdf version


^ Top



N

New Pegylated Interferons: Assessing the Impact of the New Longer Acting Interferons on the Hepatitis C Market static version printer friendly pdf version
New Targets and Drug Discovery Platforms in Antifungal R&D static version printer friendly pdf version


^ Top



O

Oxford Handbook of Genitourinary Medicine, HIV and AIDS, First Edition static version printer friendly pdf version


^ Top



P

Partneringdesk Deals and alliances in infectious diseases static version printer friendly pdf version
Partneringreview 2006: Biopharma Deal Making By Therapy Area - Infectious Diseases static version printer friendly pdf version
Pharmaceuticals and Politics: Will Political Opinion Affect the Future of HPV Vaccines? static version printer friendly pdf version
Pipeline Perspectives: Hepatitis B and C - Antivirals Challenge the Interferons? static version printer friendly pdf version
Pipeline Perspectives: Hepatitis B and C - Antivirals Challenge the Interferons? static version printer friendly pdf version


^ Top



R

Respiratory Syncytial Virus: Can Antivirals Make the Grade? static version printer friendly pdf version


^ Top



S

Sexually Transmitted Infections - The Silent Menace static version printer friendly pdf version
Stakeholder Insight: HIV Therapy Dynamics static version printer friendly pdf version
Stakeholder Opinions: Biologics in Infectious Diseases - Well Defined Target Populations are Key to Commercial Success static version printer friendly pdf version
Strategic Perspective 2001: The Hospital Antibacterial Market - Economic Constraints Drive Development of Niche Products static version printer friendly pdf version
Strategic Perspectives 2001: Infectious Diseases in Emerging Markets - Creating a Strategy for Success static version printer friendly pdf version
Strategic Perspectives 2001: The Antiviral Market - A Market For Expanding Indications static version printer friendly pdf version
Strategic Perspectives 2001: Vaccines static version printer friendly pdf version
Strategic Perspectives: Opportunistic Infections in HIV static version printer friendly pdf version
Superficial Fungal Infections. Brand Awareness - the key to success? static version printer friendly pdf version
Systemic Antifungal Infections - Impact of the Latestage Pipeline static version printer friendly pdf version


^ Top



T

Target Product Profiles 2008: Physician Insights on Key Attributes - Community-Acquired Pneumonia static version printer friendly pdf version
Target Product Profiles 2008: Physician Insights on Key Attributes - Hepatitis C Virus static version printer friendly pdf version
The Chinese hepatitis B market - Overcoming hurdles to investment static version printer friendly pdf version
The Global Antivirals Market: R&D Pipelines, Market Analysis and Competitive Landscape static version printer friendly pdf version
The Infectious Disease Market in 2001: A Year in Review static version printer friendly pdf version
The Next Generation Antifungals: Triazoles vs. Peptides static version printer friendly pdf version
Therapeutic Monoclonal Antibodies Marketed and In-Development Products static version printer friendly pdf version
Therapeutic Polyclonal Antibody Products Marketed and In-Development Products static version printer friendly pdf version
Travelers’ Infectious Diseases: Exploiting the World of Travel Vaccines? static version printer friendly pdf version
Treatment Algorithms 2002: Hepatitis B and C static version printer friendly pdf version
Tuberculosis: Trends, Challenges, and Opportunities in a Resurging Market static version printer friendly pdf version


^ Top



U

U.S. Infectious Disease Vaccine Pipeline static version printer friendly pdf version
U.S. Non-Infectious Disease Vaccine Pipeline static version printer friendly pdf version

All rights reserved. © copyright 2006 Research and Markets
Terms and conditions Privacy Policy